Details

NameSymbolSector
SHUKRA PHARMACEUTICALS LIMITEDSHUKRAPHARPharmaceuticals
Open
17.95
High
17.95
Low
17.95
Close
17.95
Volume
21428
Exchange
bse
Time
14/08

Outlook

Score:  

1

Rating:  

RISKY

Candlestick Pattern

Candle pattern of Shukra Pharmaceuticals is  
Doji
Estimated Stoploss of Shukra Pharmaceuticals is ₹  
17.95
Shukra Pharmaceuticals has a  
Bearishℹ
 pattern. 
Formation of  
Doji
 candle pattern indicates the trend direction of Shukra Pharmaceuticals is  
Unpredictableℹ
. 

Trend

Shukra Pharmaceuticals is in  
Strong Downtrendℹ
. 
Price of Shukra Pharmaceuticals is  
Downℹ
 by  

2.34

%. 
Target
Buy @ 

13.22

Sell @ 

20.28

Volume

The trade volumes of Shukra Pharmaceuticals have become  
Deficientℹ
The volume trend for Shukra Pharmaceuticals is  
Bearishℹ
, but the participants are  
Weak Sellersℹ
The trade volume of Shukra Pharmaceuticals is  

Down

 by  

85.29

% 

Valuation

The current market price of Shukra Pharmaceuticals is  
Overvaluedℹ

Financials

Balance
The balance sheet of Shukra Pharmaceuticals is:  

Balanced

Cashflow
Shukra Pharmaceuticals has  
Maintainedℹ
 cash flow because there is  

Surplus

 of  

₹ 2cr

. It is  
Downℹ
 by  

66.67

%. 

(*Mar 2025)

58.33% i.e. ₹ 7cr earned in operatingℹ
8.33% i.e. ₹ 1cr spent in investingℹ
33.33% i.e. ₹ 4cr spent in financingℹ
0% in otherℹ
Shukra Pharmaceuticals has  
Excellentℹ
 cash flow because there is  

Surplus

 of  

₹ 6cr

. It is  
Upℹ
 by  

100

%. 

(*Mar 2024)

27.78% i.e. ₹ 5cr spent in operatingℹ
5.56% i.e. ₹ 1cr spent in investingℹ
66.67% i.e. ₹ 12cr earned in financingℹ
0% in otherℹ
Income
The income of Shukra Pharmaceuticals is  

₹ 6cr

 and  

Profit

 is :  

₹ 1cr

(*Jun 2025)

Shukra Pharmaceuticals Profit is down by:  

80

% and Income is Down by:  

57.14

% 

(*Jun 2025)

The income of Shukra Pharmaceuticals is  

₹ 14cr

 and  

Profit

 is :  

₹ 5cr

(*Mar 2025)

Shukra Pharmaceuticals Profit is up by:  

66.67

% and Income is Up by:  

27.27

% 

(*Mar 2025)

The income of Shukra Pharmaceuticals is  

₹ 11cr

 and  

Profit

 is :  

₹ 3cr

(*Dec 2024)

Shukra Pharmaceuticals Profit is up by:  

300

% and Income is Up by:  

83.33

% 

(*Dec 2024)

By using this site you agree to the use of cookies to deliver a better site experience.